NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.05
+0.04 (0.13%)
Mar 24, 2026, 3:58 PM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Biotechnology (Startups)
22.50M45.56M14.09M102.69M-
Biotechnology (Startups) Growth
-50.61%223.37%-86.28%--
Total
22.50M45.56M14.09M102.69M-
Total Growth
-50.61%223.37%-86.28%--
Source: S&P Global Market Intelligence.